GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
Več na: https://www.wired.com/story/weight-loss-drug-zepbound-is-being-tested-as-a-treatment-for-long-covid/